Publicacións en colaboración con investigadores/as de University of Missouri (16)

2024

  1. Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries

    Heart and Lung, Vol. 68, pp. 131-144

2023

  1. A Simple Procedure to Measure the Tidal Volume Delivered by Mechanical Ventilators: A Tool for Bedside Verification and Quality Control

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 61-62

  2. Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium

    PLoS ONE, Vol. 18, Núm. 1 January

  3. Potential pitfalls in the use of real-world data for studying long COVID

    Nature Medicine

2022

  1. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  2. International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality

    npj Digital Medicine, Vol. 5, Núm. 1

  3. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Treatment of Multisystem Inflammatory Syndrome in Children

    New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22

  3. Vision, challenges and opportunities for a plant cell atlas

    eLife, Vol. 10

2017

  1. Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis

    DMM Disease Models and Mechanisms, Vol. 10, Núm. 5, pp. 551-558

2008

  1. Cervarix - Preventing cervical cancer and other diseases related to HPV

    Drugs in Context, Vol. 4, Núm. 1, pp. 59-70

  2. Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups

    Drugs in Context, Vol. 4, Núm. 1, pp. 71-84

  3. Gardasil - Preventing cervical cancer and other diseases related to HPV

    Drugs in Context, Vol. 4, Núm. 1, pp. 29-40

  4. Inegy - Effective combination treatment to target LDL-C levels

    Drugs in Context, Vol. 4, Núm. 1, pp. 41-58

  5. Tiotropium - Advancing the treatment of COPD

    Drugs in Context, Vol. 4, Núm. 1, pp. 15-28